ImageneBio (IMA) Net Cash Flow (2020 - 2025)

ImageneBio has disclosed Net Cash Flow across 6 years of filings, most recently posting $96.5 million for Q3 2025.

• In Q3 2025, Net Cash Flow rose 40.23% year-over-year to $96.5 million; the TTM figure through Sep 2025 stood at $16.3 million (up 298.72% YoY), while the FY2024 annual figure was -$80.9 million, down 233.99% from the prior year.
• Net Cash Flow came in at $96.5 million for Q3 2025 at ImageneBio, up from $1.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $118.5 million in Q1 2021 to a low of -$185.3 million in Q1 2022.
• Average Net Cash Flow over 5 years is -$3.7 million, with a median of -$7.2 million recorded in 2022.
• Year-over-year, Net Cash Flow surged 1288.76% in 2021 and plunged 5256.69% in 2024.
• Over 5 years, Net Cash Flow stood at -$13.7 million in 2021, then jumped by 47.71% to -$7.2 million in 2022, then jumped by 80.67% to -$1.4 million in 2023, then sank by 5256.69% to -$74.1 million in 2024, then soared by 230.23% to $96.5 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were $96.5 million in Q3 2025, $1.1 million in Q2 2025, and -$7.2 million in Q1 2025.